Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (171-180 of 439) with videos related to

Pageof 44
Sort By:
Journal for Immunotherapy of Cancer|February 16, 2020
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancerAmi N Shah, Lisa Flaum, Irene Helenowski, et al.
Cancers|January 11, 2022
Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast CancerPaolo D'Amico, Carolina Reduzzi, Wenan Qiang, et al.
Breast Cancer Research and Treatment|September 28, 2014
Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapyYinzhi Lai, Juan P Palazzo, Massimo Cristofanilli, et al.
Cancer|June 22, 2010
Detection of minimal residual disease in blood and bone marrow in early stage breast cancerSavitri Krishnamurthy, Massimo Cristofanilli, Balraj Singh, et al.
Cancer|September 24, 2004
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatmentAna M Gonzalez-Angulo, Massimo Cristofanilli, Eric A Strom, et al.
Therapeutic Advances in Medical Oncology|August 28, 2019
Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancerUgo De Giorgi, Michal Mego, Emanuela Scarpi, et al.
Clinical Breast Cancer|May 18, 2012
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancerUgo De Giorgi, Michal Mego, Emanuela Scarpi, et al.
Oncotarget|November 17, 2016
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trialsRicardo Costa, Benedito A Carneiro, Mark Agulnik, et al.
The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.
Cancer|July 29, 2006
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approachMassimo Cristofanilli, Savitri Krishnamurthy, Laura Guerra, et al.
Pageof 44

Showing results (171-180 of 439) with videos related to

Sort By:
Pageof 44
Journal for Immunotherapy of Cancer|February 16, 2020
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancerAmi N Shah, Lisa Flaum, Irene Helenowski, et al.
Cancers|January 11, 2022
Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast CancerPaolo D'Amico, Carolina Reduzzi, Wenan Qiang, et al.
Breast Cancer Research and Treatment|September 28, 2014
Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapyYinzhi Lai, Juan P Palazzo, Massimo Cristofanilli, et al.
Cancer|June 22, 2010
Detection of minimal residual disease in blood and bone marrow in early stage breast cancerSavitri Krishnamurthy, Massimo Cristofanilli, Balraj Singh, et al.
Cancer|September 24, 2004
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatmentAna M Gonzalez-Angulo, Massimo Cristofanilli, Eric A Strom, et al.
Therapeutic Advances in Medical Oncology|August 28, 2019
Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancerUgo De Giorgi, Michal Mego, Emanuela Scarpi, et al.
Clinical Breast Cancer|May 18, 2012
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancerUgo De Giorgi, Michal Mego, Emanuela Scarpi, et al.
Oncotarget|November 17, 2016
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trialsRicardo Costa, Benedito A Carneiro, Mark Agulnik, et al.
The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.
Cancer|July 29, 2006
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approachMassimo Cristofanilli, Savitri Krishnamurthy, Laura Guerra, et al.
Pageof 44